INTRODUCTION
============

Gastric cancers and colorectal cancers (CRCs) are the leading cause of cancer-related death in Korea. In Korea, nationwide screening for gastric cancer and CRC have been performed as a part of National Cancer Screening Program (NCSP) for Medical Aid recipients and National Health Insurance beneficiaries in the lower 50% income bracket.[@b1-gnl-10-699] For gastric cancer screening, either esophagogastroduodenoscopy (EGD) or gastrointestinal series are provided biennially for adults aged 40 years or older.[@b2-gnl-10-699] For CRC screening, fecal occult blood tests (FOBTs) are provided annually as the primary screening method for adults aged 50 years or older, and follow-up investigation by either colonoscopy or double contrast barium enema are provided for individuals with a positive FOBT.[@b3-gnl-10-699],[@b4-gnl-10-699]

To improve the endoscopic quality of NCSP, the Korean Society of Gastrointestinal Endoscopy (KSGE) developed the National Endoscopy Quality Improvement Program (NEQIP).[@b5-gnl-10-699]--[@b8-gnl-10-699] This program incorporates qualifications of endoscopists, quality improvement for instruments available at the endoscopy unit and endoscopic procedures (including sedation and reprocessing of endoscopes), as well as measurement of outcomes of endoscopy screening.[@b5-gnl-10-699]--[@b8-gnl-10-699] Recently, many quality indicators for gastrointestinal endoscopy were published,[@b9-gnl-10-699]--[@b11-gnl-10-699] and the importance of quality improvement in gastrointestinal endoscopy has been underlined. Although a better understanding of the characteristics of nationwide screening endoscopy, endoscopic capacity, current state of sedation and reprocessing of endoscope, and opinion for NEQIP may be the first step towards a successful widespread adoption of nationwide screening endoscopy, the current state of these data for screening endoscopies have never been evaluated in Korea.

In this context, we evaluated the current status of the NCSP, endoscopic capacity, sedation and reprocessing, as well as opinion for NEQIP in Korea.

MATERIALS AND METHODS
=====================

1. Study subjects
-----------------

This survey was conducted between July 2015 and August 2015 for all physician performing screening EGD and/or colonoscopy as a part of the NCSP. Physicians who were performing screening EGD and/or colonoscopy of NCSP in 2014 and members of the KSGE were selected for potential respondents. Physicians were excluded from the study if a valid e-mail address could not be located or if the questionnaire was not answered completely. The KSGE Ethics and Quality Improvement Committee approved the questionnaire. This study was approved by the Institutional Review Board at the Kyung Hee University Hospital at Gangdong (KHNMC IRB 2015-07-015).

2. Questionnaire development and survey administration
------------------------------------------------------

A 32-item survey instrument was developed based on literature review[@b5-gnl-10-699]--[@b11-gnl-10-699] and semistructured discussions with community and academic gastroenterologists. Members of the Ethics and Quality Improvement Committee of KSGE also reviewed the survey instrument. The survey was designed to determine the current state of the NCSP, the endoscopic capacity, sedation, reprocessing of endoscopes, as well as opinion for NEQIP. The questionnaire was piloted among gastroenterology fellows of the Kyung Hee University Hospital at Gangdong. Feedback from this group was used to establish face and content validity and to revise the content of the survey instrument. Reported completion times ranged from 15 to 20 minutes. A link to a web-based version of the survey using the host SurveyMonkey (<http://www.surveymonkey.com>) was e-mailed to all potential respondents. All responses were anonymous and voluntary. In this survey system, duplicated submissions from the same respondent were prevented. We offered token incentives, including ₩100,000 gift card, for three participants by random sampling. We sent a reinvitation e-mail to all potential respondents for three times, and the web-based survey was closed after 4 weeks.

3. Statistical analysis
-----------------------

Descriptive statistics were used to summarize sociodemographic characteristics. Categorical data were expressed as number (percentage), whereas continuous data were expressed as mean±standard deviations. Statistical analyses were performed using the SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

1. Characteristics of respondents and their endoscopy units
-----------------------------------------------------------

A total of 547 physicians responded to the web-based survey, with a total response rate of 18.8% (547/2,906). Overall, 507 survey results were analyzed after exclusion of 40 incomplete answers. [Table 1](#t1-gnl-10-699){ref-type="table"} shows the characteristics of respondents and endoscopy units performing screening endoscopies in NCSP. The respondents included 393 men (77.5%) and 114 women (22.5%), with a mean age of 41.9±7.3 years. Most respondents (84.2%) were gastroenterologists with fellow training more than 1 year, sufficient cumulative endoscopy volume, and continuous medical education for endoscopy. For provider specialty, most endoscopies were performed by a gastroenterologist (\~63.3%), followed by an internal physician (25.4%), and by other specialties (8.2%). Approximately 41.0% of respondents were working at primary clinics/hospitals, and the remainder in tertiary or training hospitals (34.3%), secondary hospitals (18.5%), and other institutions (6.1%). The mean number of endoscopy examination rooms was 3.5 per endoscopy units, and 31.6% of endoscopy units consisted of only one endoscopy examination room.

2. Endoscopic capacity of the NCSP
----------------------------------

Under current capacity of NCSP, typical waiting time for screening endoscopy was less than 4 weeks in more than 90% (93.5% for EGD and 90.7% for colonoscopy). Respondents estimated the potential maximum weekly number of endoscopies in addition to those in current practice that could be performed with current available resources. The potential maximum weekly number of EGDs and colonoscopies was about 54 and 17 cases, respectively. Respondents were asked about the overall obstacles (multiple choices) and three major obstacles (single choice) to perform more screening endoscopies at their practice site to accommodate an increased endoscopic demand ([Table 2](#t2-gnl-10-699){ref-type="table"}). The major three limiting factors were insufficient financial reimbursement (50.1%), insufficient time (12.2%) and insufficient nursing staffs (9.3%). In a separate survey question, the respondents were asked about the strategies that would be considered in practice to accommodate an increased endoscopic demand. The most common response was that physicians would not consider performing more endoscopies (38.9%). Respondents were next more likely to increase the proportion of working hours allocated to endoscopic procedures (16.0%) and would hire more nursing staffs to assist with endoscopies (11.8%).

3. Sedation and reprocessing of endoscopy
-----------------------------------------

For the survey of sedation ([Table 3](#t3-gnl-10-699){ref-type="table"}), two respondents were excluded from the analysis since sedative endoscopy was not performed in their endoscopy units. The most commonly used sedative agents were a combination of benzodiazepine and propofol (58.2%), followed by benzodiazepine alone (30.1%), propofol alone (7.3%), a combination of etomidate and other agents (3.4%), or other agents (1.0%). Majority of physicians obtained informed consent and monitored patients for conscious sedation (95.2% and 96.2%, respectively).

In the survey for reprocessing of endoscopes ([Table 3](#t3-gnl-10-699){ref-type="table"}), 103 respondents were excluded from the analysis due to incomplete answers. The most commonly used disinfectants were glutaral-dehyde (27.5%), followed by ortho-phthalaldehyde (24.5%), peracetic acid (13.1%), and superoxidized water (6.9%). However, 28.0% of respondents used disinfectants that had not been approved by the Korean Food and Drug Administration or didn't know main ingredient of their disinfectants. Approximately 15% to 17% of respondents did not follow reprocessing protocols, i.e., 17.3% of respondents did not sterilize accessories that break the mucosal barrier and 15.1% did not perform high-level disinfection for accessories attached to the endoscope. Most (84.2%) of respondents underwent continuous medical education for reprocessing of endoscopic equipment.

4. Opinions for the NEQIP
-------------------------

For survey items regarding opinions for NEQIP ([Table 4](#t4-gnl-10-699){ref-type="table"}), 137 respondents were excluded from the analysis because of incomplete answers. Only 37.3% of respondents were very familiar or familiar with NEQIP criteria. Common reasons for gaps between NEQIP criteria and clinical practice were that "physician could not follow NEQIP criteria in clinical practice" (43.5%) or "physician was not familiar with NEQIP criteria" (32.4%). Over 60% of respondents agreed that "NEQIP provides benefits for many of their patients" and "NEQIP would improve early diagnosis of gastric cancer or CRC." However, 66.8% and 58.1% of respondents were concerned about "NEQIP could be used in physician discipline" and "NEQIP could decrease physician reimbursement," respectively. Nearly half of the respondents agreed on the necessity of revising the NEQIP criteria, and only 14.6% of respondents felt no need for revision of NEQIP. Over 80% of respondents wanted simplified NEQIP criteria applicable in clinical practice, and approximately 2/3 of respondents asked for streamlining the NEQIP criteria, clarifications of their definitions and performance targets, and scientific evidence supporting the NEQIP criteria.

DISCUSSION
==========

This study presents the current status of the nationwide screening endoscopy, endoscopic capacity, sedation and reprocessing, as well as opinion for NEQIP in Korea. Of all physicians who responded to our survey, gastroenterologists performed most of the nationwide screening endoscopy in NCSP, and most of them had gastroenterology fellow training for more than 1 year with a sufficient cumulative endoscopy volume. Under current capacity of NCSP, typical waiting time for screening endoscopies in NCSP was less than 4 weeks in over 90% of the endoscopy units, which was very short compared with those of other countries.[@b12-gnl-10-699]--[@b14-gnl-10-699] In a survey of an Asian tertiary care hospital,[@b12-gnl-10-699] 62% of patients had to wait for more than 4 weeks for their appointment, and a long waiting time was the main cause of patient dissatisfaction. In clinical practice guidelines established in Spain, the waiting time from positive FOBTs to colonoscopy was recommended to be less than 6 weeks.[@b13-gnl-10-699] Furthermore, a Canadian consensus recommended screening colonoscopy should be performed within 6 months.[@b14-gnl-10-699] The shorter waiting time for screening endoscopies in NCSP is likely due to the high number of available endoscopists and endoscopy units in Korea.

In the present survey, obstacles and strategies to accommodate an increased endoscopic demand in NCSP were questioned. The major obstacle was insufficient endoscopy reimbursement. As a result, most physicians were not likely to plan to perform more screening endoscopies in NCSP. For example, the medical cost of a screening EGD in NCSP was \$34.89 in 2008,[@b15-gnl-10-699] which was approximately 1/20 of the medical cost in the United States (\$685 for EGD alone).[@b16-gnl-10-699] Our survey result may suggest that insufficient reimbursement could be a barrier to accommodate the increased endoscopic demand in the future. Furthermore, insufficient reimbursement may lead to a low quality of endoscopy. The next response to accommodate an increased endoscopic demand was that physicians would increase working hours for endoscopy, which was a similar result from the U.S. survey.[@b17-gnl-10-699] Therefore, further studies optimizing reimbursement for screening endoscopy in NCSP are warranted in Korea.

For sedation, benzodiazepine was the most commonly used form of sedation, either alone or in combination with other drugs, and propofol alone was used in only 7.3% of patients. In a nationwide survey from Spain,[@b18-gnl-10-699] benzodiazepine was used in 30% of patients for EGD and colonoscopy, respectively, and propofol was used in 70% of EGDs and in 80% of colonoscopies, respectively. In a recent nationwide survey from Korea,[@b19-gnl-10-699] benzodiazepine was used in combination with propofol in 25.3% of EGDs and in 33.8% of colonoscopies, and propofol alone was used in 29.0% of EGDs and 6.0% of colonoscopies, respectively. It seems likely that higher participation of endoscopists from primary clinic in that study[@b19-gnl-10-699] may be a possible explanation for higher preference for propofol use compared with our data. The widespread use of propofol for gastrointestinal endoscopy has also been documented in several European countries.[@b20-gnl-10-699],[@b21-gnl-10-699] As the characteristics of propofol include a rapid onset of action with a short-term effect, a shorter recovery time, and greater patient and endoscopist satisfaction,[@b22-gnl-10-699] propofol use may be preferred by endoscopists practicing in primary clinic setting.[@b19-gnl-10-699] Our survey findings suggested suboptimal performance of endoscopy reprocessing, as 28% of respondents used unapproved disinfectants or did not know main ingredient of their disinfectants as well as 15% to 17% of respondents did not follow reprocessing protocols.[@b23-gnl-10-699] A Chinese survey from 122 endoscopy units and an Italian survey from 278 endoscopy units also showed significant room for improvement in the practice of endoscopic reprocessing.[@b24-gnl-10-699],[@b25-gnl-10-699] Our survey findings suggest that there are substantial gaps between clinical practice and reprocessing guideline recommendations, and highlight the need for improving performance of reprocessing protocols.

Physician awareness, familiarity, and agreement were potential barriers to NEQIP adherence.[@b26-gnl-10-699] Our survey findings showed relatively optimal agreement of NEQIP as only 5.7% of respondents do not agree with NEQIP, however, its familiarity was suboptimal as only 37.3% of respondents were familiar with NEQIP criteria. Therefore, efforts to improve familiarity with NEQIP may be necessary. Low familiarity with NEQIP may partially be explained by that physicians concerned that NEQIP would likely be used in physician discipline and thus decrease physician reimbursement.

Our survey results need to be interpreted in the context of the potential limitations. The generalizability of this study may be limited as respondents' response tendencies may differ that from nonrespondents or variable practice settings. In addition, as we limited the study population to endoscopists who performed screening endoscopy in NCSP, our results may therefore not be generalizable to other endoscopists who do not perform endoscopy in NCSP. Like most survey study, this survey also totally relied on the knowledge and the answer of the respondents. Even though, our study has several strengths. First, this is the first study on the current status of the NCSP, endoscopic capacity, sedation and reprocessing as well as endoscopists' opinions for NEQIP in Korea. Second, the questionnaire development was performed by discussion with academic and community gastroenterologists, and reviewed by members of the Ethics and Quality Improvement Committee of KSGE. For this survey, we used a number of evidence-based strategies to maximize responses, including short survey length, multiple contacts, and incentives. Finally, a large number of gastroenterologists responded to our survey from various institutional levels. Therefore, our survey results may represent the universal opinion of all gastroenterologists in Korea.

In conclusion, NEQIP is still suboptimal in Korea. Considering suboptimal performance of endoscopy reprocessing and low awareness and agreement of NEQIP, the implementation of quality in endoscopy reprocessing and a better understanding of NEQIP should be underlined in Korea.
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###### 

Characteristics of Survey Respondents and Respective Endoscopy Units Participating in the National Cancer Screening Program

  Characteristic                                          Value
  ------------------------------------------------------- -------------------
  Survey respondents                                      
   Age, yr                                                41.9±7.3
   Male sex                                               393 (77.5)
   Specialty[\*](#tfn3-gnl-10-699){ref-type="table-fn"}   
    Gastroenterologists                                   342 (67.5)
    Other specialties (including internal medicine)       163 (32.1)
   Fellowship for endoscopy training ≥1 yr                427 (84.2)
   Cumulative endoscopy volume                            
    EGD ≥500 cases                                        484 (95.5)
    Colonoscopy ≥150 cases                                469 (92.5)
   Continuous medical education for endoscopy             485 (95.7)
  Endoscopy unit                                          
   Practice site                                          
    Primary clinic/hospital                               208 (41.0)
    Secondary hospital                                    94 (18.5)
    Tertiary or training hospital                         174 (34.3)
    Others (military hospital/health promotion center)    31 (6.1)
   Proportion of specialties in the endoscopy unit        
    Gastroenterologists                                   63.3 (60.3--66.4)
    Internal medicine (excluding gastroenterology)        25.4 (22.6--28.2)
    Others                                                8.2 (6.6--9.8)
   No. of endoscopy examination rooms                     3.5±3.2

Data are presented as mean±SD, number (%), or percent (95% CI).

EGD, esophagogastroduodenoscopy; CI, confidence interval.

Two general practitioners respondents were excluded from the analysis.

###### 

Endoscopic Capacity in the National Cancer Screening Program

  Endoscopic capacity                                                           Value
  ----------------------------------------------------------------------------- ------------
  Typical waiting time (\<4 wk) for endoscopy                                   
   EGD                                                                          474 (93.5)
   Colonoscopy                                                                  460 (90.7)
  Potential maximum number of endoscopies in addition to current practice       
   No. of EGD per week                                                          53.6±96.8
   No. of colonoscopy per week                                                  17.0±31.0
  Limiting factors to performing more endoscopies (multiple choices)            
   Insufficient time                                                            265 (52.3)
   Insufficient utilization due to cancellations or no shows                    208 (41.0)
   Insufficient number of physicians                                            168 (33.1)
   Insufficient nursing staff                                                   284 (56.0)
   Insufficient procedure rooms, preparatory and/or recovery areas              263 (51.9)
   Insufficient endoscopes or monitors                                          199 (39.3)
   Insufficient reimbursement                                                   384 (75.7)
  Major obstacles to performing more endoscopies (single choice)                
   Insufficient reimbursement                                                   254 (50.1)
   Insufficient time                                                            63 (12.2)
   Insufficient nursing or ancilary staff                                       47 (9.3)
  Strategies taken to meet the increased endoscopic demand (multiple choices)   
   Not applicable, not planning to perform more endoscopies                     275 (54.2)
   Increase working hours allocated to endoscopy                                254 (50.1)
   Use of reminder calls to decrease cancellations or no shows                  272 (53.6)
   Increase medical staff                                                       237 (46.7)
   Increase nursing staff                                                       329 (64.9)
   Establish more procedure rooms, prep and/or recovery areas                   269 (53.1)
   Purchase or lease more equipment                                             255 (50.3)
  Major strategies to meet the increased endoscopic demand (single choice)      
   Not applicable, not planning to perform more endoscopies                     197 (38.9)
   Increase working hours allocated to endoscopy                                81 (16.0)
   Increase nursing staff                                                       60 (11.8)

Data are presented as number (%) or mean±SD.

EGD, esophagogastroduodenoscopy.

###### 

Characteristics of Sedatives for Endoscopy and Reprocessing of Endoscopes

  Characteristic                                                      Value
  ------------------------------------------------------------------- ------------
  Sedative endoscopy[\*](#tfn7-gnl-10-699){ref-type="table-fn"}       
   Sedative agents                                                    
    Benzodiazepine alone                                              152 (30.1)
    Propofol alone                                                    37 (7.3)
    Combination of benzodiazepine and propofol                        294 (58.2)
    Combination of etomidate and other agents                         17 (3.4)
    Other agents                                                      5 (1.0)
   Informed consent for sedative endoscopy                            481 (95.2)
   Patient monitoring during sedative endoscopy                       486 (96.2)
  Endoscopic reprocessing[†](#tfn8-gnl-10-699){ref-type="table-fn"}   
   Disinfectants used                                                 
    Glutaraldehyde                                                    111 (27.5)
    Ortho-phthalaldehyde                                              99 (24.5)
    Peracetic acid                                                    53 (13.1)
    Superoxidized water                                               28 (6.9)
    Other agents or did not know main ingredient                      113 (28.0)
   Sterilization of accessories that pass the mucosal barrier         334 (82.7)
   High-level disinfection of accessories attached to the endoscope   343 (84.9)
   Continuous medical education for endoscopic reprocessing           340 (84.2)

Data are presented as number (%).

Two respondents were excluded from the analysis because they did not administer any sedatives for endoscopy;

One hundred three respondents were excluded from analysis because their survey responses were incomplete.

###### 

Opinions on the Revision of the National Endoscopy Quality Improvement Program

  Opinion for revision of NEQIP                                             Value[\*](#tfn11-gnl-10-699){ref-type="table-fn"}
  ------------------------------------------------------------------------- ---------------------------------------------------
  Familiarity with NEQIP                                                    
   1 (very familiar)                                                        57 (15.4)
   2                                                                        81 (21.9)
   3                                                                        130 (35.1)
   4                                                                        61 (16.5)
   5 (very unfamiliar)                                                      41 (11.1)
  Reason for gap between NEQIP and clinical practice                        
   Physician is not familiar with NEQIP                                     120 (32.4)
   Physician does not agree with NEQIP                                      21 (5.7)
   Physician cannot follow NEQIP in real practice                           161 (43.5)
   Physician is not motivated due to insufficient reimbursement             68 (18.4)
  Opinion for current NEQIP                                                 
   NEQIP helps improve quality of endoscopy                                 211 (57.0)
   NEQIP is supported by evidence-based studies                             173 (46.8)
   NEQIP increases early diagnosis of gastric cancer or colorectal cancer   223 (60.3)
   NEQIP provides benefits for many of my patients                          255 (68.9)
   NEQIP does not apply to many of my patients                              142 (38.4)
   NEQIP is likely to be used in physician discipline                       247 (66.8)
   NEQIP is likely to decrease the physician's reimbursement                215 (58.1)
  Opinion for the revision of the NEQIP                                     
   To clarify the definition and performance target of NEQIP                252 (68.1)
   To support scientific evidence of NEQIP                                  247 (66.8)
   To apply NEQIP easily in clinical practice                               299 (80.8)
   To simplify NEQIP criteria                                               256 (69.2)

Data are presented as number (%).

NEQIP, National Endoscopy Quality Improvement Program.

One hundred thirty-seven respondents were excluded from the analysis because they provided incomplete responses to survey items.
